eXoZymes Inc. (EXOZ)
Цена, главные цифры и свежие новости — всё на одной странице.
eXoZymes Inc. (EXOZ): цена акции, анализ и данные
| Бид | 8.2 |
| Рыночная капитализация | 66.53M |
| Выручка (TTM) | n/a |
| Чистая прибыль (TTM) | -10.19M |
| n/a | |
| -1.2 | |
| n/a | |
| n/a | |
| P/B (TTM) | 18.19 |
| P/S (TTM) | n/a |
| Дата отчёта | n/a |
| Аск | 7.6 |
| Объём торгов | 2,688 |
| Ср. объём (20д) | 9,514 |
| Открытие | 7.01 |
| Пред. закрытие | 7.17 |
| Диапазон дня | 6.71 - 7.38 |
| Диапазон за 52 недели | 4.35 - 18.40 |
| Аналитики | n/a |
| Целевая цена | n/a |
| Дивиденды | n/a |
| Дата отсечки | n/a |
О компании EXOZ
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California....
Финансовые результаты
В 2025 году выручка eXoZymes составила 0 — это рост на undefined% к прошлогодним 0. Прибыль составила -9.16M — это рост на 56.26%.
Финансовая отчётность
1 неделю назад · GuruFocus.com
MDB Capital Holdings LLC (MDBH) (Q2 2026) Earnings Call Highlights: Strategic Pivots and Asset ...CEO Christopher Marlett outlines a leaner operational model, potential partnerships for Public Ventures, and a PatentVest spin-out as key catalysts to unlock shareholder value.
5 месяцев назад · GuruFocus.com
EXoZymes Inc (EXOZ) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial ChallengesEXoZymes Inc (EXOZ) showcases its innovative biomanufacturing platform and strategic focus on NCT and cannabinoids, while navigating financial hurdles and market skepticism.